Last week, the FDA announced recalls for seven food products and two prescription medications due to problems ranging from mislabeling to the presence of bacterial contamination and glass particles.
While the agency is tasked with the regulation of food and medical products, the recalls themselves are voluntarily issued first by the companies, then publicized by the FDA to protect the public.
Below, DrugNews provides more information on these recalls, as well as what steps the public should take if they are affected.
FDA Food Recalls
On May 8th, Publix Supermarkets announced a recall of their Publix Deli Artichoke and Spinach Dip sold in refrigerated sections of the deli due to the possibility of the product containing small glass fragments.
The recall affects the 16 oz. containers sold at Publix stores in Alabama, Florida, Georgia, Tennessee, South Carolina and North Carolina with a UPC of 000-41415-15961, and a use-by-date of May 16.
Customers are urged to return any affected containers to their nearest store.
On May 9th, Fourth Street Barbeque issued a recall of its Chicken & Waffle Sandwiches sold at Save-A-Lot supermarkets due to the risk that the waffles might be contaminated with Listeria monocytogenes, a bacteria that can cause severe infections in elderly people or young children.
The recall affects the 14.4 ounce boxes of the sandwiches with UPC code 051933353664. So far, no illnesses have been reported.
Also on May 9th, A.S.K. Foods announced a recall of its Potato Salad sold at Wegmans Supermarkets due to the undisclosed presence of eggs, which can cause allergic reactions in some people.
The recall affects the 48 ounce clear plastic containers sold in Wegman’s store in New York, Pennsylvania and Massachusetts with a UPC of 77890 24678 and a sell-by date of 5/7/17.
On May 10th, Mikawaya Foods announced a recall of its Chocolate Mochi Ice Cream sold at Trader Joe’s stores nationwide, due to the possible undisclosed presence of peanuts, which may cause allergic reactions in some.
The recall affects Lot number 090-17, which is sold in 9.1 ounce boxes with UPC code 070934990609.
On May 11th, Trident Seafoods issued a recall of certain packages of its frozen Multi-Grain Alaskan Cod due to the possibility that they may contain small plastic particles that can present a choking hazard.
The recall affects 12 ounce packages with UPC code 0 28029 21048 4 and Best-by dates of 11/30/2018 or 12/27/2018.
Also on May 11th, Lamb Weston Company announced a recall of its Red Robin brand Crispy Onion Rings sold in 14 ounce packages in various supermarkets around the country due to the possibility the product may contain undisclosed milk.
The recall does not affect any onion rings sold in Red Robin restaurants.
Finally, on May 12th, Whole Foods Market announced the recall of Oatmeal Chocolate Chip Cookies sold in its New Orleans store due to the possible presence of Walnuts which were not disclosed on packaging and may cause allergic reactions.
FDA Drug & Medical Device Warnings
On May 8th, New Jersey based Truxton Pharmaceuticals announced the further recall of various dosages of their Phenobarbital and Amitriptyline tablets due to the possibility the medications were mislabeled.
Phenobarbital is prescribed as both a sedative and anticonvulsant. Amitriptyline is prescribed as a tricyclic antidepressant in both animals and humans.
If taken by mistake, phenobarbital has the potential to cause intoxication that can result in liver failure, shock, coma or death in in humans and animals. Amitriptyline, if taken inadvertently, can result in confusion, sleepiness, nausea, vomiting, stiffness, seizures, fainting or irregular heartbeat.
For more information on these drug warnings and product recalls, visit the Food and Drug Administration’s website at www.FDA.gov, or contact DrugNews today.
FDA. Recalls, Market Withdrawals & Safety Alerts. (May 15, 2017). Retrieved from http://www.fda.gov/Safety/Recalls/default.htm
The U.S. Food and Drug Administration has identified a troubling number of reports of both pancreatitis and liver damage among patients taking the popular rheumatoid arthritis drug Actemra.
Families suing drug maker GlaxoSmithKline over alleged birth defects from their anti-nausea medication Zofran have raised new charges that the company hid safety data from the FDA and is blocking evidence of false advertising.